225 related articles for article (PubMed ID: 11891502)
1. How many pathways to pheochromocytoma?
Neumann HP; Hoegerle S; Manz T; Brenner K; Iliopoulos O
Semin Nephrol; 2002 Mar; 22(2):89-99. PubMed ID: 11891502
[TBL] [Abstract][Full Text] [Related]
2. Genetic basis of phaeochromocytoma and paraganglioma.
Benn DE; Robinson BG
Best Pract Res Clin Endocrinol Metab; 2006 Sep; 20(3):435-50. PubMed ID: 16980204
[TBL] [Abstract][Full Text] [Related]
3. Pheochromocytoma/Paraganglioma: Is This a Genetic Disorder?
Fishbein L
Curr Cardiol Rep; 2019 Jul; 21(9):104. PubMed ID: 31367972
[TBL] [Abstract][Full Text] [Related]
4. Familial pheochromocytoma.
Erlic Z; Neumann HP
Hormones (Athens); 2009; 8(1):29-38. PubMed ID: 19269919
[TBL] [Abstract][Full Text] [Related]
5. Familial pheochromocytomas and paragangliomas: stories from the sign-out room.
Perren A; Komminoth P
Endocr Pathol; 2006; 17(4):337-44. PubMed ID: 17525482
[TBL] [Abstract][Full Text] [Related]
6. [Familial pheochromocytoma].
Tamura N; Nakao K
Nihon Rinsho; 2006 May; Suppl 1():730-4. PubMed ID: 16776261
[No Abstract] [Full Text] [Related]
7. Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.
Dannenberg H; Komminoth P; Dinjens WN; Speel EJ; de Krijger RR
Endocr Pathol; 2003; 14(4):329-50. PubMed ID: 14739490
[TBL] [Abstract][Full Text] [Related]
8. Pheochromocytoma: the expanding genetic differential diagnosis.
Bryant J; Farmer J; Kessler LJ; Townsend RR; Nathanson KL
J Natl Cancer Inst; 2003 Aug; 95(16):1196-204. PubMed ID: 12928344
[TBL] [Abstract][Full Text] [Related]
9. New insights into the genetics of familial chromaffin cell tumors.
Koch CA; Vortmeyer AO; Zhuang Z; Brouwers FM; Pacak K
Ann N Y Acad Sci; 2002 Sep; 970():11-28. PubMed ID: 12381538
[TBL] [Abstract][Full Text] [Related]
10. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
Neumann HP; Eng C; Mulligan LM; Glavac D; Zäuner I; Ponder BA; Crossey PA; Maher ER; Brauch H
JAMA; 1995 Oct; 274(14):1149-51. PubMed ID: 7563486
[TBL] [Abstract][Full Text] [Related]
11. Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor.
Elder EE; Elder G; Larsson C
J Surg Oncol; 2005 Mar; 89(3):193-201. PubMed ID: 15719371
[TBL] [Abstract][Full Text] [Related]
12. [Pediatric pheochromocytoma and paraganglioma: an update].
Garnier S; Réguerre Y; Orbach D; Brugières L; Kalfa N
Bull Cancer; 2014 Oct; 101(10):966-75. PubMed ID: 25373696
[TBL] [Abstract][Full Text] [Related]
13. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.
Neumann HP; Berger DP; Sigmund G; Blum U; Schmidt D; Parmer RJ; Volk B; Kirste G
N Engl J Med; 1993 Nov; 329(21):1531-8. PubMed ID: 8105382
[TBL] [Abstract][Full Text] [Related]
14. [Genetic tests in oncology practice with emphasis on the RET oncogene and VHL tumor suppressor gene].
Nesković G; Stanojević B; Palmar I; Dimitrijević B
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():52-7. PubMed ID: 12584999
[TBL] [Abstract][Full Text] [Related]
15. Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine/Head and Neck Disease-Site Work Group. Part 1 of 2: Advances in Pathogenesis and Diagnosis of Pheochromocytoma and Paraganglioma.
Patel D; Phay JE; Yen TWF; Dickson PV; Wang TS; Garcia R; Yang AD; Solórzano CC; Kim LT
Ann Surg Oncol; 2020 May; 27(5):1329-1337. PubMed ID: 32112212
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of erythropoietin and its receptor in von hippel-lindau-associated and multiple endocrine neoplasia type 2-associated pheochromocytomas.
Vogel TW; Brouwers FM; Lubensky IA; Vortmeyer AO; Weil RJ; Walther MM; Oldfield EH; Linehan WM; Pacak K; Zhuang Z
J Clin Endocrinol Metab; 2005 Jun; 90(6):3747-51. PubMed ID: 15769989
[TBL] [Abstract][Full Text] [Related]
17. Isolated familial pheochromocytoma as a variant of von Hippel-Lindau disease.
Ritter MM; Frilling A; Crossey PA; Höppner W; Maher ER; Mulligan L; Ponder BA; Engelhardt D
J Clin Endocrinol Metab; 1996 Mar; 81(3):1035-7. PubMed ID: 8772572
[TBL] [Abstract][Full Text] [Related]
18. Pheochromocytoma in von Hippel-Lindau disease and neurofibromatosis type 1.
Opocher G; Conton P; Schiavi F; Macino B; Mantero F
Fam Cancer; 2005; 4(1):13-6. PubMed ID: 15883705
[TBL] [Abstract][Full Text] [Related]
19. Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome.
Erlic Z; Hoffmann MM; Sullivan M; Franke G; Peczkowska M; Harsch I; Schott M; Gabbert HE; Valimäki M; Preuss SF; Hasse-Lazar K; Waligorski D; Robledo M; Januszewicz A; Eng C; Neumann HP
J Clin Endocrinol Metab; 2010 Jan; 95(1):308-13. PubMed ID: 19906784
[TBL] [Abstract][Full Text] [Related]
20. Perioperative outcomes of syndromic paraganglioma and pheochromocytoma resection in patients with von Hippel-Lindau disease, multiple endocrine neoplasia type 2, or neurofibromatosis type 1.
Butz JJ; Yan Q; McKenzie TJ; Weingarten TN; Cavalcante AN; Bancos I; Young WF; Schroeder DR; Martin DP; Sprung J
Surgery; 2017 Dec; 162(6):1259-1269. PubMed ID: 28919049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]